4:40 PM - 4:48 PM
○Tadashi NOSAKA1, Katsuhiko HAGI1, Andrei PIKALOV2 (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)
[CNP] Poster Session
CNP » [CNP] Poster Session
Sat. Oct 12, 2019 4:40 PM - 5:25 PM Poster Hall (Multi-purpose Hall)
座長:上村 誠(溝の口メンタルクリニック)
10月11日(金) 13:40~15:10 ポスター会場(福岡国際会議場 2階 多目的ホール)
10月12日(土) 16:40~17:25 ポスター会場(福岡国際会議場 2階 多目的ホール)
4:40 PM - 4:48 PM
○Tadashi NOSAKA1, Katsuhiko HAGI1, Andrei PIKALOV2 (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)
4:48 PM - 4:56 PM
○Tadashi NOSAKA1, Katsuhiko HAGI1, Andrei PIKALOV2 (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)
4:56 PM - 5:04 PM
○Tadashi NOSAKA1, Katsuhiko HAGI1, Andrei PIKALOV2 (1. Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals, Inc, Marlborough, MA and Fort Lee, NJ, USA)
5:04 PM - 5:12 PM
○Keisuke ASANO1, 2, Takefumi SUZUKI1, 3, Akira NISHI2, Aki ENDO2, Ai GOUNARIDIS2, Masaru MIMURA2, Hiroyuki UCHIDA2 (1. Department of Psychiatry, Inokashira Hospital, Tokyo, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 3. Department of Neuropsychiatry and Clinical Ethics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan)